Cargando…

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

OBJECTIVE: Cotadutide, a dual GLP-1 and glucagon receptor agonist, is under development for nonalcoholic steatohepatitis (NASH) and chronic kidney disease with type 2 diabetes. The effects of cotadutide on hepatic and metabolic parameters were evaluated in participants with overweight/obesity and ty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nahra, Rajaa, Wang, Tao, Gadde, Kishore M., Oscarsson, Jan, Stumvoll, Michael, Jermutus, Lutz, Hirshberg, Boaz, Ambery, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2021
Materias:	Cardiovascular and Metabolic Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247525/ https://www.ncbi.nlm.nih.gov/pubmed/34016612 http://dx.doi.org/10.2337/dc20-2151

Ejemplares similares

Correlates of cardiorespiratory fitness among overweight or obese individuals with type 2 diabetes
por: Kaze, Arnaud D, et al.
Publicado: (2022)

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
por: Lee, Christine G., et al.
Publicado: (2021)

Changes in Adipose Tissue Depots and Metabolic Markers Following a 1-Year Diet and Exercise Intervention in Overweight and Obese Patients With Type 2 Diabetes
por: Gallagher, Dympna, et al.
Publicado: (2014)

Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program
por: Perreault, Leigh, et al.
Publicado: (2022)

Effect of 8 Weeks of Overfeeding on Ectopic Fat Deposition and Insulin Sensitivity: Testing the “Adipose Tissue Expandability” Hypothesis
por: Johannsen, Darcy L., et al.
Publicado: (2014)

Effects of Interrupting Sedentary Behavior With Short Bouts of Moderate Physical Activity on Glucose Tolerance in Children With Overweight and Obesity: A Randomized Crossover Trial
por: Broadney, Miranda M., et al.
Publicado: (2018)

Effect of High-Intensity Interval Training on Glycemic Control in Adults With Type 1 Diabetes and Overweight or Obesity: A Randomized Controlled Trial With Partial Crossover
por: Lee, Angela S., et al.
Publicado: (2020)

Ethnic differences in serum lipids and lipoproteins in overweight/obese African-American and white American women with pre-diabetes: significance of NMR-derived lipoprotein particle concentrations and sizes
por: Gaillard, Trudy, et al.
Publicado: (2016)

Serum levels of mac-2 binding protein are associated with diabetic microangiopathy and macroangiopathy in people with type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Polygenic Prediction of Type 2 Diabetes in Africa
por: Chikowore, Tinashe, et al.
Publicado: (2022)

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
por: Rossing, Peter, et al.
Publicado: (2022)

Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus
por: Ghanem, Samar Ebrahim, et al.
Publicado: (2020)

Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life
por: Longato, Enrico, et al.
Publicado: (2020)

Effect of SARS-CoV-2 Infection and Infection Severity on Longer-Term Glycemic Control and Weight in People With Type 2 Diabetes
por: Wong, Rachel, et al.
Publicado: (2022)

Incidence of type 2 diabetes in familial combined hyperlipidemia
por: Brouwers, Martijn C G J, et al.
Publicado: (2020)

Management of type 2 diabetes in chronic kidney disease
por: Triozzi, Jefferson L, et al.
Publicado: (2021)

Glycemic variability and cardiovascular disease in patients with type 2 diabetes
por: Martinez, Marcela, et al.
Publicado: (2021)

Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
por: Lomonaco, Romina, et al.
Publicado: (2016)

Cardiovascular Determinants of Aerobic Exercise Capacity in Adults With Type 2 Diabetes
por: Gulsin, Gaurav S., et al.
Publicado: (2020)

Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus
por: Matsumoto, Chisa, et al.
Publicado: (2022)

Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial
por: Dagogo-Jack, Samuel, et al.
Publicado: (2021)

Hyperglycemia and Stroke Mortality: Comparison between fasting and 2-h glucose criteria
por: Hyvärinen, Marjukka, et al.
Publicado: (2009)

Evaluation of vitamin D relationship with type 2 diabetes and systolic blood pressure
por: Nayak, Shivananda Bijoor, et al.
Publicado: (2016)

A Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia Treatment
por: Mariam, Arshiya, et al.
Publicado: (2021)

Changes in Triglyceride Levels Over Time and Risk of Type 2 Diabetes in Young Men
por: Tirosh, Amir, et al.
Publicado: (2008)

Objectively assessed physical activity, adiposity, and inflammatory markers in people with type 2 diabetes
por: Hamer, Mark, et al.
Publicado: (2014)

Intensity of statin therapy and new hospitalizations for heart failure in patients with type 2 diabetes
por: Kishimoto, Ichiro, et al.
Publicado: (2015)

Circulating SerpinB1 levels and clinical features in patients with type 2 diabetes
por: Takebayashi, Kohzo, et al.
Publicado: (2016)

Breakfast skipping is associated with persistently increased arterial stiffness in patients with type 2 diabetes
por: Mita, Tomoya, et al.
Publicado: (2020)

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
por: Schwartz, Gregory G., et al.
Publicado: (2021)

Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study
por: Zhao, Maoxiang, et al.
Publicado: (2021)

Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease
por: Birukov, Anna, et al.
Publicado: (2022)

Alcohol Consumption, Mediating Biomarkers, and Risk of Type 2 Diabetes Among Middle-Aged Women
por: Beulens, Joline W.J., et al.
Publicado: (2008)

Cardiovascular Risk Factors Among Youth With and Without Type 2 Diabetes: Differences and possible mechanisms
por: West, Nancy A., et al.
Publicado: (2009)

Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia
por: Bello, Natalie A, et al.
Publicado: (2014)

Subclinical Atherosclerosis Is Inversely Associated With Gray Matter Volume in African Americans With Type 2 Diabetes
por: Freedman, Barry I., et al.
Publicado: (2015)

Risk of hypertension in middle-aged and elderly participants with newly diagnosed type 2 diabetes and prediabetes
por: Sasaki, Nobuo, et al.
Publicado: (2020)

Serum calcification propensity is associated with HbA1c in type 2 diabetes mellitus
por: Mencke, Rik, et al.
Publicado: (2021)

Associations between physical activity and trimethylamine N-oxide in those at risk of type 2 diabetes
por: Argyridou, Stavroula, et al.
Publicado: (2020)

Physical activity and cardiometabolic health in adolescents with type 2 diabetes: a cross-sectional study
por: Slaght, Jana L, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ut5sttc7e19gb5cfgqrrgsgfc9